5 completed, 1 recruiting, 1 unknown, 1 withdrawn. 3 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Methylnaltrexone bromide: new trials by email Literature Review of Methylnaltrexone bromide trials Research Report on Methylnaltrexone bromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics Relistor Injectable Product - Chronic Widespread Pain | Not applicable | Recruiting | Florida International University | 200 | 2021-11-15 | 2026-09-11 |
| A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer Methylnaltrexone bromide, Placebo - Pancreatic Cancer | Phase 2 / Phase 3 | Withdrawn | Bausch Health Americas, Inc. | 2020-01-06 | 2021-05-07 | |
| The Effect of Naloxone and Methylnaltrexone on Esophageal Sensitivity in Health Naloxone, Methylnaltrexone Bromide, Placebo - Endogenous and Esophageal Sensitivity | Not applicable | Completed | Universitaire Ziekenhuizen KU Leuven | 12 | 2013-10-01 | 2017-01-09 |
| Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects Methylnaltrexone bromide - Healthy Adult Subjects | Phase 1 | Completed | Bausch Health Americas, Inc. | 20 | 2010-07-01 | 2019-11-29 |
| Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit Methylnaltrexone Bromide, Placebo-Normal Saline - Opioid-induced Constipation | Phase 3 | Unknown | St. John Health System, Michigan | 80 | 2009-12-01 | 2010-01-15 |
| Methylnaltrexone for Opioid-induced Constipation in Cancer Patients Methylnaltrexone bromide - Neoplasms, Constipation | Phase 2 | Completed | University of Vermont | 12 | 2009-10-01 | 2016-02-02 |
| Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness Methylnaltrexone bromide - Opioid-Induced Constipation | Phase 4 | Completed | Bausch Health Americas, Inc. | 156 | 2008-07-01 | 2018-03-07 |
| Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures Methylnaltrexone bromide, Placebo - Opioid-induced Constipation | Phase 2 | Completed | Bausch Health Americas, Inc. | 37 | 2007-10-19 | 2019-09-04 |
Opioid-Induced Constipation (3) · Constipation (2) · Chronic Pain (1) · Gastroesophageal Reflux (1) · Neoplasms (1) · Opioid-Related Disorders (1) · Pancreatic Neoplasms (1)
Bausch Health Americas, Inc. (4) · Florida International University (1) · St. John Health System, Michigan (1) · Universitaire Ziekenhuizen KU Leuven (1) · University of Vermont (1)
United States (7) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Mexico (1) · Portugal (1) · United Kingdom (1)
Bradford A Whitmer, D.O. (1) · Enoch Bortey (1) · Jan Tack, MD, PhD (1) · John Lahey (1) · Lindsey Mathew (1) · Saurabh Aggarwal, MD., PhD (1) · Steven Ades, MD (1) · Tage Ramakrishna, MD (1)